Skip to main content
. 2022 Jul 20;23(14):8012. doi: 10.3390/ijms23148012
ALT Alternative lengthening of telomeres
AML Acute myeloid leukemia
APL Acute promyelocytic leukemia
AR Androgen receptor
CRC Colorectal cancer
DCs Dendritic cells
DDR DNA damage response
DSBs Double strand breaks
EBV Epstein-Barr virus
EC Endometrial cancer
ER Estrogen receptor
EMT Epithelial to mesenchymal transition
GBM Glioblastoma
GC Gastric cancer
HCC Hepatocellular carcinoma
HDAC Histone deacetylase
HNC Head and neck cancer
KO Knock out
MM Multiple myeloma
MI Momordin Ic
NBs Nuclear bodies
NPC Nuclear pore complex
NSCLC Non-small-cell lung cancer
OGD Oxygen and glucose deprivation
OSCC Oral squamous cell carcinoma
PCa Prostate cancer
PTM Post-translational modification
ROS Reactive oxygen species
SIM SUMO interacting motif
TNBC Triple-negative breast cancer
UBLs Ubiquitin-like modifiers